Jpmorgan Chase & CO Integra Lifesciences Holdings Corp Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 309,732 shares of IART stock, worth $3.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
309,732
Previous 199,691 55.11%
Holding current value
$3.92 Million
Previous $4.53 Million 50.42%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$21.13 - $26.55 $2.33 Million - $2.92 Million
110,041 Added 55.11%
309,732 $6.81 Million
Q4 2024

Feb 12, 2025
BUY
$16.95 - $26.7 $1.92 Million - $3.02 Million
113,061 Added 130.51%
199,691 $4.53 Million
Q3 2024

Dec 26, 2024
SELL
$17.14 - $31.74 $347,582 - $643,655
-20,279 Reduced 18.97%
86,630 $1.57 Million
Q3 2024

Nov 08, 2024
SELL
$17.14 - $31.74 $347,582 - $643,655
-20,279 Reduced 18.97%
86,630 $1.57 Million
Q2 2024

Dec 26, 2024
BUY
$23.14 - $34.72 $469,256 - $704,086
20,279 Added 23.41%
106,909 $3.12 Million
Q2 2024

Aug 12, 2024
SELL
$23.14 - $34.72 $1.06 Million - $1.6 Million
-45,972 Reduced 30.07%
106,909 $3.12 Million
Q1 2024

Dec 26, 2024
BUY
$33.4 - $45.2 $2.21 Million - $2.99 Million
66,251 Added 76.48%
152,881 $5.42 Million
Q1 2024

May 10, 2024
SELL
$33.4 - $45.2 $76,786 - $103,914
-2,299 Reduced 1.48%
152,881 $5.42 Million
Q4 2023

Dec 26, 2024
BUY
$34.21 - $44.59 $2.35 Million - $3.06 Million
68,550 Added 79.13%
155,180 $6.76 Million
Q4 2023

Feb 12, 2024
SELL
$34.21 - $44.59 $362,386 - $472,341
-10,593 Reduced 6.39%
155,180 $6.76 Million
Q3 2023

Nov 14, 2023
SELL
$37.8 - $45.97 $1.15 Million - $1.4 Million
-30,530 Reduced 15.55%
165,773 $6.33 Million
Q2 2023

Aug 11, 2023
BUY
$37.95 - $58.98 $326,445 - $507,345
8,602 Added 4.58%
196,303 $8.07 Million
Q1 2023

May 18, 2023
BUY
$52.61 - $60.49 $6.57 Million - $7.55 Million
124,862 Added 198.7%
187,701 $10.8 Million
Q1 2023

May 11, 2023
SELL
$52.61 - $60.49 $5.6 Million - $6.44 Million
-106,410 Reduced 62.87%
62,839 $3.61 Million
Q4 2022

Feb 13, 2023
SELL
$42.17 - $58.6 $1.38 Million - $1.92 Million
-32,703 Reduced 16.19%
169,249 $9.49 Million
Q3 2022

Nov 14, 2022
BUY
$42.28 - $57.17 $960,939 - $1.3 Million
22,728 Added 12.68%
201,952 $8.55 Million
Q2 2022

Aug 11, 2022
BUY
$53.86 - $66.52 $1.32 Million - $1.63 Million
24,542 Added 15.87%
179,224 $9.68 Million
Q1 2022

May 11, 2022
SELL
$62.86 - $69.24 $536,635 - $591,101
-8,537 Reduced 5.23%
154,682 $9.94 Million
Q4 2021

Feb 10, 2022
BUY
$62.47 - $73.25 $1.3 Million - $1.52 Million
20,789 Added 14.6%
163,219 $10.9 Million
Q3 2021

Nov 12, 2021
BUY
$64.97 - $76.19 $9.25 Million - $10.9 Million
142,430 New
142,430 $9.75 Million

Others Institutions Holding IART

# of Institutions
241
Shares Held
79.3M
Call Options Held
23.3K
Put Options Held
2.3K
View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

IART Quotes by TradingView
  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.06B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email